Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Storm Newton

Weight loss jabs could keep heart failure patients out of hospital

The weight loss and type 2 diabetes drugs semaglutide and tirzepatide could slash the risk of patients with a type of heart failure being hospitalised, research shows.

The jabs are sold under and more commonly known by their brand names Ozempic, Wegovy and Mounjaro.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.